Literature DB >> 19639232

Microarray analysis suggests that burn injury results in mitochondrial dysfunction in human skeletal muscle.

A Aria Tzika1, Dionyssios Mintzopoulos, Michael Mindrinos, Jiangwen Zhang, Laurence G Rahme, Ronald G Tompkins.   

Abstract

Burn injuries to extensive areas of the body are complicated by muscle catabolism. Elucidating the molecular mechanisms that mediate this catabolism may facilitate the development of a medical intervention. Here, we assessed the functional classification of genes that were differentially expressed in skeletal muscle following burn injury in 19 children (5.2+/-4.0 years of age), (64+/-15% total burn surface area, TBSA) relative to 13 healthy controls (11.9+/-6.0 years of age). Microarray analysis of samples taken within 10 days of burn injury revealed altered expression of a variety of genes, including some involved in cell and organelle organization and biogenesis, stress response, wound response, external stimulus response, regulation of apoptosis and intracellular signaling. The genes that encode peroxisome proliferator-activated receptors (PPARs; 3 isotypes PPARalpha, PPARgamma and PPARdelta also known as PPARbeta or PPARbeta/delta), which may serve as transcriptional nodal points and therapeutic targets for metabolic syndromes, were among those affected. In particular, expression of the main mitochondrial biogenesis factor PPARgamma-1beta (or PGC-1beta) was downregulated (P<0.0001), while the expression of PPARdelta was upregulated (P<0.001). Expression of PGC-1alpha, the closest homolog of PGC-1beta was upregulated (P=0.0037), and expression of the gene encoding mitochodrial uncoupling protein 2 (UCP2) was also upregulated (P=0.008). These results suggest that altered PPAR and mitochondrial gene expression soon after burn injury may lead to metabolic and mitochondrial dysfunction in human skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639232      PMCID: PMC3207251          DOI: 10.3892/ijmm_00000244

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  35 in total

1.  In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism.

Authors:  G W Cline; A J Vidal-Puig; S Dufour; K S Cadman; B B Lowell; G I Shulman
Journal:  J Biol Chem       Date:  2001-03-27       Impact factor: 5.157

Review 2.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

Review 3.  Nuclear receptors and other nuclear transcription factors in mitochondria: regulatory molecules in a new environment.

Authors:  Anna-Maria G Psarra; Constantine E Sekeris
Journal:  Biochim Biophys Acta       Date:  2007-11-13

4.  Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor.

Authors:  Jiandie Lin; Pere Puigserver; Jerry Donovan; Paul Tarr; Bruce M Spiegelman
Journal:  J Biol Chem       Date:  2001-11-30       Impact factor: 5.157

Review 5.  The metabolic basis of the increase of the increase in energy expenditure in severely burned patients.

Authors:  Y M Yu; R G Tompkins; C M Ryan; V R Young
Journal:  JPEN J Parenter Enteral Nutr       Date:  1999 May-Jun       Impact factor: 4.016

6.  Reduced rate of adenosine triphosphate synthesis by in vivo 31P nuclear magnetic resonance spectroscopy and downregulation of PGC-1beta in distal skeletal muscle following burn.

Authors:  A Aria Tzika; Dionyssios Mintzopoulos; Katie Padfield; Julie Wilhelmy; Michael N Mindrinos; Hongue Yu; Haihui Cao; Qunhao Zhang; Loukas G Astrakas; Jiangwen Zhang; Yong-Ming Yu; Laurence G Rahme; Ronald G Tompkins
Journal:  Int J Mol Med       Date:  2008-02       Impact factor: 4.101

7.  Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs.

Authors:  Göksel Sener; A Ozer Sehirli; Nursal Gedik; Gül Ayanoğlu Dülger
Journal:  Burns       Date:  2007-04-30       Impact factor: 2.744

Review 8.  Oxidative stress and anti-oxidative mobilization in burn injury.

Authors:  Arti Parihar; Mordhwaj S Parihar; Stephen Milner; Satyanarayan Bhat
Journal:  Burns       Date:  2007-10-01       Impact factor: 2.744

9.  The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.

Authors:  Uwe Dressel; Tamara L Allen; Jyotsna B Pippal; Paul R Rohde; Patrick Lau; George E O Muscat
Journal:  Mol Endocrinol       Date:  2003-10-02

10.  Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.

Authors:  Davide Genini; Giuseppina M Carbone; Carlo V Catapano
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more
  16 in total

1.  Novel mitochondria-targeted antioxidant peptide ameliorates burn-induced apoptosis and endoplasmic reticulum stress in the skeletal muscle of mice.

Authors:  Hyung-yul Lee; Masao Kaneki; Jonathan Andreas; Ronald G Tompkins; J A Jeevendra Martyn
Journal:  Shock       Date:  2011-12       Impact factor: 3.454

Review 2.  The Role of Mitochondrial Stress in Muscle Wasting Following Severe Burn Trauma.

Authors:  John O Ogunbileje; David N Herndon; Andrew J Murton; Craig Porter
Journal:  J Burn Care Res       Date:  2018-01-01       Impact factor: 1.845

3.  Uncoupled skeletal muscle mitochondria contribute to hypermetabolism in severely burned adults.

Authors:  Craig Porter; David N Herndon; Elisabet Børsheim; Tony Chao; Paul T Reidy; Michael S Borack; Blake B Rasmussen; Maria Chondronikola; Manish K Saraf; Labros S Sidossis
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-07-29       Impact factor: 4.310

Review 4.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 5.  Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

Authors:  Itoro E Elijah; Elisabet Børsheim; Dirk M Maybauer; Celeste C Finnerty; David N Herndon; Marc O Maybauer
Journal:  Burns       Date:  2012-01-09       Impact factor: 2.744

6.  Mitochondria-targeted antioxidant promotes recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P nuclear magnetic resonance and electron paramagnetic resonance spectroscopy.

Authors:  Valeria Righi; Caterina Constantinou; Dionyssios Mintzopoulos; Nadeem Khan; S P Mupparaju; Laurence G Rahme; Harold M Swartz; Hazel H Szeto; Ronald G Tompkins; A Aria Tzika
Journal:  FASEB J       Date:  2013-03-12       Impact factor: 5.191

7.  Long-Term Skeletal Muscle Mitochondrial Dysfunction is Associated with Hypermetabolism in Severely Burned Children.

Authors:  Craig Porter; David N Herndon; Elisabet Børsheim; Nisha Bhattarai; Tony Chao; Paul T Reidy; Blake B Rasmussen; Clark R Andersen; Oscar E Suman; Labros S Sidossis
Journal:  J Burn Care Res       Date:  2016 Jan-Feb       Impact factor: 1.845

Review 8.  The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.

Authors:  David S Fedson; Steven M Opal
Journal:  Hum Vaccin Immunother       Date:  2013-02-07       Impact factor: 3.452

Review 9.  Evaluation of in vivo mitochondrial bioenergetics in skeletal muscle using NMR and optical methods.

Authors:  Matthew D Campbell; David J Marcinek
Journal:  Biochim Biophys Acta       Date:  2015-12-17

10.  Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency.

Authors:  Cloé M Julienne; Jean-François Dumas; Caroline Goupille; Michelle Pinault; Cécile Berri; Anne Collin; Sophie Tesseraud; Charles Couet; Stephane Servais
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.